Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide government funding notice banner was added and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:22:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a glossary toggle in the header and introduced metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision updated to v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria' (lowercase 'met'), 'No FEAR Act data', and the previous revision note v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:16:24.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    47 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-22T23:53:13.000Z thumbnail image
  5. Check
    68 days ago
    Change Detected
    Summary
    The page revision label updated from v3.3.1 to v3.3.2. No substantive study information appears to be changed.
    Difference
    0.1%
    Check dated 2025-12-01T16:34:07.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The Publications section is now described as automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:42:20.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Removed the banner notice about a lapse in government funding and the NIH operating status, which previously directed users to opm.gov for status updates. This change affects only operational messaging and does not alter the study details, eligibility criteria, or listed results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:17:44.000Z thumbnail image

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.